Nanog Predicts Poor Prognosis in Human Pancreatic Cancer and Is Downregulated by QingyihuaJi Formula in Pancreatic Cancer Stem Cells

Qingyihuaji formula (QYHJ), confirmed efficacious in a series of clinical trials, has been applied to human pancreatic carcinoma treatment in Shanghai Cancer Center for years. Recent evidence highlighted that pluripotent stem cells transcription factor Nanog plays a pivotal role in carcinogenesis. H...

Descripción completa

Detalles Bibliográficos
Autores principales: Gao, Song, Pan, Yan, Song, Libin, Dong, Lei, Weng, Lao I., Wang, Peng, Hua, Yongqiang, Chen, Zhen, Liu, Luming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5086502/
https://www.ncbi.nlm.nih.gov/pubmed/27829864
http://dx.doi.org/10.1155/2016/7028289

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5086502/
https://www.ncbi.nlm.nih.gov/pubmed/27829864
http://dx.doi.org/10.1155/2016/7028289

Ejemplares similares